City

Philadelphia (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Sidney Kimmel Cancer Center at Thomas Jefferson University (1)

Collaborator

Genentech, Inc. (1)

Pharmacyclics LLC. (1)

Intervention

ibrutinib (1)

obinutuzumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

stage ii splenic marginal zone lymphoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Non-Hodgkin's Lymphoma, Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor

Recruiting

Non-Hodgkin's Lymphoma
+18 more

Philadelphia, Pennsylvania

Sidney Kimmel Cancer Center at Thomas Jefferson University

Mar 11, 2021